ProShares UltraShort Health Care
4 hedge funds and large institutions have $227K invested in ProShares UltraShort Health Care in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
30% more capital invested
Capital invested by funds: $175K → $227K (+$52.3K)
12% more call options, than puts
Call options by funds: $22M | Put options by funds: $19.6M
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.84% less ownership
Funds ownership: 7.68% → 6.83% (-0.84%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$73.2K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$659 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$66.3K |
RXD Hedge Fund Activity: Q4 2024 in Review
4 of the 7,605 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q4 2024, worth a combined $227K — up 30% from $175K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new RXD positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $73.2K. The largest seller was UBS Group, cutting an estimated $66.3K.
- 4 institutional investors held ProShares UltraShort Health Care (RXD) as of Q4 2024, up from 3 in Q3 2024.
- Funds reported $227K of ProShares UltraShort Health Care stock for Q4 2024, up 30% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest ProShares UltraShort Health Care buyer in Q4 2024 was Susquehanna International Group, an estimated $73.2K added.
- The largest ProShares UltraShort Health Care seller in Q4 2024 was UBS Group, an estimated $66.3K sold.
Based on aggregated 13F filings for Q4 2024.